Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 50 | 14/07/21 | |
Director of Finance/CFO | 69 | 11/01 | |
Stuart Rich
CTO | Chief Tech/Sci/R&D Officer | 74 | 15/01/21 |
Doug Randall
COO | Chief Operating Officer | - | 14/11/13 |
Douglas Hay
LAW | General Counsel | - | 14/11/13 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gerry Proehl
CHM | Chairman | 65 | 04/04/14 |
June Almenoff
BRD | Director/Board Member | 67 | 25/02/21 |
Declan Doogan
BRD | Director/Board Member | 72 | 25/02/21 |
Michael Davidson
BRD | Director/Board Member | 67 | 25/02/21 |
Robyn Hunter
BRD | Director/Board Member | 62 | 28/01/22 |
Stuart Rich
CTO | Chief Tech/Sci/R&D Officer | 74 | 15/01/21 |
Chief Executive Officer | 50 | 14/07/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 210 | 0 | 0 | 99,65 % |
Azione B | 1 | 1 958 245 | 1 951 297 ( 99,65 %) | 0 |
Coordinate società
Tenax Therapeutics, Inc.
101 Glen Lennox Drive Suite 300
27517, Chapel Hill
+(919) 855-2100
http://www.tenaxthera.com![Indirizzo Tenax Therapeutics Inc](https://cdn.zonebourse.com/static/address/18045260.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+40,80% | 53,67 Mrd | |
+35,79% | 38,86 Mrd | |
-8,05% | 38,76 Mrd | |
-8,98% | 27,27 Mrd | |
+10,69% | 25,91 Mrd | |
-16,21% | 20,29 Mrd | |
+31,00% | 12,78 Mrd | |
+28,51% | 12,18 Mrd | |
-1,67% | 11,96 Mrd |